| CAT No: | CL-DABT-54 |
| CAS No: | NA |
| Mol.F: | C31H30D3N7O9 |
| Mol.Wt.: | 650.7 |
| Rel. Cas No: | |
| Chemical Name: | (2S,3S,4S,5R,6S)-6-((3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-(methyl-d3)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Dabigatran Acyl-beta-D-Glucuronide-D3 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Dabigatran Acyl-beta-D-Glucuronide-D3 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(2S,3S,4S,5R,6S)-6-((3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-(methyl-d3)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Dabigatran Molecular Formula: C31H30D3N7O9
Molecular Weight: 650.7
Storage: Store in a cool, dry place.
| Product Name: | Dabigatran Acyl-beta-D-Glucuronide-D3 |
| CAS No: | |
| Mol.F.: | C31H30D3N7O9 |
| Mol.Wt.: | 650.7 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: